
The Aurora zzso have been the subject of considerable interest as targets for the development of new zzso zzso While evidence suggests zzso of Aurora B zzso gives rise to the more pronounced zzso zzso the most clinically advanced agents reported to date typically inhibit both Aurora A and zzso We have discovered a series of zzso some of which show greater than zzso selectivity for Aurora B over Aurora A zzso activity, in zzso zzso zzso These compounds have been designed for zzso administration and achieve high levels of zzso by virtue of their ability to be delivered as readily activated zzso zzso The zzso are zzso converted to the zzso form in zzso and the active species have advantageous zzso properties and safety pharmacology zzso The compounds display striking in zzso activity, and compound 5 zzso has been selected for clinical evaluation and is currently in phase 1 clinical zzso 

